Literature DB >> 26134100

Transcatheter aortic valve implantation: long-term clinical outcome and valve durability.

Jakub Sulzenko1, Petr Tousek, Viktor Kocka, Petr Widimsky.   

Abstract

Transcatheter aortic valve implantation (TAVI) is a widely used intervention in patients who are at high risk or contraindicated for cardiac surgery. The procedure is technically feasible in most patients and has very good mid-term clinical outcomes. In this special report, we evaluated the long-term outcome after TAVI and durability of percutaneously implanted aortic valve prostheses by reviewing all available long-term follow-up data. We herein present the clinical and hemodynamic data derived from patients 2-5 years after TAVI and describe all published cases of prosthesis degeneration.

Entities:  

Keywords:  TAVI; degeneration; long-term outcome; mortality; valve hemodynamics

Mesh:

Year:  2015        PMID: 26134100     DOI: 10.1586/17434440.2015.1063994

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  4 in total

1.  A correlation between long-term in vitro dynamic calcification and abnormal flow patterns past bioprosthetic heart valves.

Authors:  Oleksandr Barannyk; Robert Fraser; Peter Oshkai
Journal:  J Biol Phys       Date:  2017-05-29       Impact factor: 1.365

Review 2.  Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond.

Authors:  Adam Chakos; Ashley Wilson-Smith; Sameer Arora; Tom C Nguyen; Abhijeet Dhoble; Giuseppe Tarantini; Matthias Thielmann; John P Vavalle; Daniel Wendt; Tristan D Yan; David H Tian
Journal:  Ann Cardiothorac Surg       Date:  2017-09

3.  A Durable Porcine Pericardial Surgical Bioprosthetic Heart Valve: a Proof of Concept.

Authors:  Benyamin Rahmani; Christopher McGregor; Guerard Byrne; Gaetano Burriesci
Journal:  J Cardiovasc Transl Res       Date:  2019-02-12       Impact factor: 4.132

4.  Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.